Search for: "U. S. v. Morgan" Results 121 - 140 of 165
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Sep 2011, 2:57 am by Andrew Lavoott Bluestone
Plaintiff has failed to make the requisite evidentiary showing establishing merit to her proposed amended claim (Joyce v McKenna Assoc. , supra; Morgan v Prospect Park Assocs. [read post]
4 Aug 2011, 3:04 pm by R Grace Rodriguez
JP Morgan Chase Bank, N.A., Nos. 09–CV–01855–LHK, 09–CV–01879, 2011 WL 864949, at *7 (N.D.Cal. [read post]
22 Jun 2011, 6:07 pm
BELOW THE FOLD IS TEXT VERSION OF DATABASE OF DEBT COLLECTORS __________________________________________________________________________________ 1ST CREDIT OF AMERICA LLC 300 N ELIZABETH ST STE 220-B CHICAGO, IL 60607 6464 INVESTMENTS LLC 1625 S IRIS WY LAKEWOOD, CO 80232-6347 A COMPLETE FINANCIAL INC 2016 OGDEN ST DENVER, CO 80205 AAA COLLECTORS INC DBA TRIPLE CHECK INC 2950 N ACADEMY BLVD UNIT 201 COLORADO SPRINGS, CO 80917 Aargon Agency Inc 3160 S… [read post]
22 Jun 2011, 6:07 pm
BELOW THE FOLD IS TEXT VERSION OF DATABASE OF DEBT COLLECTORS __________________________________________________________________________________ 1ST CREDIT OF AMERICA LLC 300 N ELIZABETH ST STE 220-B CHICAGO, IL 60607 6464 INVESTMENTS LLC 1625 S IRIS WY LAKEWOOD, CO 80232-6347 A COMPLETE FINANCIAL INC 2016 OGDEN ST DENVER, CO 80205 AAA COLLECTORS INC DBA TRIPLE CHECK INC 2950 N ACADEMY BLVD UNIT 201 COLORADO SPRINGS, CO 80917 Aargon Agency Inc 3160 S… [read post]
22 Apr 2011, 1:58 am by Andrew Lavoott Bluestone
  It's hiding inAccess Point Med., LLC v Mandell ;2011 NY Slip Op 30866(U) April 8, 2011 Supreme Court, New York County Docket Number: 102082/2010 Here is how it goes. [read post]
23 Feb 2011, 4:02 pm by INFORRM
The Times, for example, will attach an “Editor’s Note” to the web version of an article to allow the subject of the article a form of redress. [read post]
16 Nov 2010, 3:16 am by Dan Frith
Rodney Gray and Morgan Stanley Smith Barney, LLC and is currently pending in the U. [read post]
3 Sep 2010, 11:42 am by FDABlog HPM
Interestingly, the Morgan Stanley report fingers AstraZeneca’s (“AZN’s”) CRESTOR (rosuvastatin calcium) Tablets as one drug product for which a PUC strategy may be beneficial. [read post]